₦airaland Forum

Welcome, Guest: Register • Login • With Google • Trending • Recent • New

Stats: 3,344,177 members, 8,510,534 topics. Date: Friday, 30 October 2026 at 02:58 PM

Toggle theme

Funny60's Posts

Nairaland Forum › Funny60's Profile › Funny60's Posts

1 2 3 4 5 6 7 8 9 10 11 12 13 (of 16 pages)

Health › Re: Permanent Cure For Asthma by funny60: 11:31pm On Sep 21, 2014
USE OF GENE THERAPY IN SICKLE CELL DISEASE
Sickle cell disease is a monogenic disorder that occurs due to point mutation at position 6 of Beta globin chain of hemoglobin molecule in which valine is being substitute for glutamic acid.
USE OF GENE THERAPY IN SICKLE CELL DISEASE
Sickle cell disease is a monogenic disorder that occurs due to point mutation at position 6 of Beta globin chain of hemoglobin molecule in which valine is being substitute for glutamic acid.
Health › Re: Cure For Sickle Cell Anaemia Advances To Clinical Stage. by funny60: 11:31pm On Sep 21, 2014
USE OF GENE THERAPY IN SICKLE CELL DISEASE
Sickle cell disease is a monogenic disorder that occurs due to point mutation at position 6 of Beta globin chain of hemoglobin molecule in which valine is being substitute for glutamic acid.
USE OF GENE THERAPY IN SICKLE CELL DISEASE
Sickle cell disease is a monogenic disorder that occurs due to point mutation at position 6 of Beta globin chain of hemoglobin molecule in which valine is being substitute for glutamic acid.
Health › Re: Aids Cured by funny60: 11:31pm On Sep 21, 2014
USE OF GENE THERAPY IN SICKLE CELL DISEASE
Sickle cell disease is a monogenic disorder that occurs due to point mutation at position 6 of Beta globin chain of hemoglobin molecule in which valine is being substitute for glutamic acid.
USE OF GENE THERAPY IN SICKLE CELL DISEASE
Sickle cell disease is a monogenic disorder that occurs due to point mutation at position 6 of Beta globin chain of hemoglobin molecule in which valine is being substitute for glutamic acid.

1 2 3 4 5 6 7 8 9 10 11 12 13 (of 16 pages)